Status:
TERMINATED
Active Vitamin D Effect on Left Ventricular Hypertrophy
Lead Sponsor:
Per Ivarsen
Conditions:
Chronic Kidney Disease
Secondary Hyperparathyroidism
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Left ventricular hypertrophy (LVH) predicts mortality at start of dialysis. Prevention of of LVH is important. It is not known whether secondary hyperparathyroidism might induce LVH. In the present st...
Eligibility Criteria
Inclusion
- Chronic kidney disease (S-creatinin \> 150 and \< 600 mikroM)
- Secondary hyperparathyroidism (Between 3-8 times the upper limit of our PTH assay)
- Stable blood pressure during the last 6 months (less than (160/95)
- B-hemoglobin \> 6 mmol/l
- EKG with sinus rhythm and no sign of Q-wave infarction
- Expected follow up 6 month
Exclusion
- Pregnancy
- Kidney transplantation
- Malignant disease
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00175149
Start Date
January 1 2002
End Date
December 1 2008
Last Update
December 8 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Renal Medicne C, Skejby Hospital
Aarhus, Denmark, 8200